Pericardial Patches Market Size & Share, by Product Type (Autologous, Xenograft, Synthetic); Source (Porcine Patch, Bovine Patch, Equine Patch); Application (Cardiovascular Surgery, Dental Surgery, Ophthalmology, Abdominal Surgery); End-user (Hospitals, Ambulatory Care Centers, Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4589
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Pericardial Patches Landscape

top-features-companies
    • Edwards Lifesciences Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Visionary Medtech Solutions
    • Abbott Laboratories
    • CryoLife, Inc.
    • LeMaitre Vascular, Inc.
    • Neovasc, Inc.
    • FOC Medical
    • W. L. Gore & Associates, Inc.
    • Baxter International Inc.
    • Collagen Solutions Plc 

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Abbott Laboratories' HEARTMATE 3 heart pump can prolong life beyond five years in patients with limited therapeutic options.

  • Edwards Lifesciences Corporation has announced that its PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation and can improve clinicians' ability to provide positive outcomes for patients with both MR and TR through a single delivery system.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4589
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rise in the prevalence of chronic diseases, improvements in pericardial patch manufacturing and sterilization, and increased use of soft tissue patches in surgeries are the major factors driving the growth of the pericardial patches market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033

Insufficient supply of grafts and increased risk of infections along with the high costs of medical products are estimated to be the growth hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott Laboratories, CryoLife, Inc., LeMaitre Vascular, Inc., Neovasc, Inc., FOC Medical, W. L. Gore & Associates, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, source, application, end user, and by region.

The cardiovascular surgery segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying